Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human
/PRNewswire/ -- Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim's selection of Veeva Development Cloud to drive...
With Veeva Development Cloud, Boehringer Ingelheim aims to establish a connected technology landscape for agile collaboration that can accelerate the development of novel medicines Transformation
Efficacy and safety data from the Effisayil™ 1 trial presented at AAD 2022 showed spesolimab is associated with rapid pustular and skin clearance ...
The Independent Data Monitoring Committee recommended that the EMPA-KIDNEY trial be stopped early, following a formal interim assessmentEMPA-KIDNE...